ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Oncology Pipeline Database 2021: Indication; Clinical Trial Stages; Drug Mechanism Classes; Competitive Landscape - ResearchAndMarkets.com

September 14, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Sep 14, 2021--

The “Oncology Pipeline Database - 2021” report has been added to ResearchAndMarkets.com’s offering.

Oncology Pipeline Highlights Database - 2021, provides the most up-to-date information on key pipeline products in the global Oncology Drug market.

It covers emerging therapies for Oncology indications in active clinical development stages including early and late-stage clinical trials. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin’s disease, Acute Myeloid Leukemia and Multiple Myeloma. The pipeline data is presented in an excel dashboard with filtering options.

ADVERTISEMENT

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:

The database presents pipeline by Oncology indications. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin’s disease, Acute Myeloid Leukemia and Multiple Myeloma.

By Clinical Trial Stages:

The database provides Oncology pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:

The database provides Oncology pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The database provides Oncology pipeline products by the company.

SUMMARY:

  • Oncology Pipeline by Indication
  • Oncology Pipeline by Clinical Trial Phase
  • Oncology Pipeline by Drug Mechanism Classes
  • Oncology Pipeline by Company

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/c6c2cq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210914005751/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 09/14/2021 09:18 AM/DISC: 09/14/2021 09:18 AM

http://www.businesswire.com/news/home/20210914005751/en